Significance - Arinna is the Goddess of the Sun, in Hittite (around 18th Century) mythology. Arinna, also known as Arinnitti. She presided over the Sun. Arinna granted an enormous supply of benefits to the planet.
Arinna the Goddess of Sun has bestowed her powers to the Sun. As we know that Sun has been there since the inception of the Earth & life and has traversed many many years, till date and beyond to support life. The experience of sun has given it the expertise to support the life on the Earth. Though the life forms on the Earth have changed in size, shape, characteristics, physiological & morphological features and in their functional aspects, however all the changes were supported by the Sun to promote, preserve and nurture life, thus we all trust the Sun. Therefor the Sun exists as epitome of experience, expertise and trust.
Arinna Lifesciences Ltd. (Arinna) has been set up by a team of experienced professionals, with a goal to tap into the fast-growing CNS/CVS segments independently.
Inception – Arinna Lifesciences is a specialty pharmaceutical company engaged in development and marketing of quality finished dosages in Indian market; established in 2013 and headquartered in Ahmedabad-India. To initiate with, Arinna shall focus on CNS therapy then gradually spread over other specialties.
Arinna employs over 400 people and covering more than 20,000 customers. Arinna has over 5 manufacturing alliances with WHO GMP certified partners to provide high quality products.
Arinna operates with 18 Regional offices, more than 680 stockists and its’ products are sold in over 23 states across the county. Its products are available in more than 5000 Chemists.
Arinna believes in delivering the shared benefits to all its stake holders (external as well as internal). Arinna would like to have all its stake holders (external as well as internal) as partners in its growth story.
Arinna understands that today’s sophisticated consumers want companies to adapt to their dynamic and un-communicated needs, to proactively reach out to them with relevant messages and offerings and take the initiatives to build a trust-based relationship with them, which aligns closely with their values.
Arinna aims for an interactive promotional strategy that would help the team to drive marketing performance by simultaneously increasing operating efficiencies and brand equity.
Arinna shall strive to achieve healthier and happier lives through meaningful medicines and other health products & services which will meet the needs of the medical practitioners, and their patients.
Arinna shall attempt and reach to become the most valued company by providing unsurpassed customer services by building, maintaining and growing strong relationships with key stakeholders.
Arinna shall endeavor new product development and innovation through research & development programs undertaken internally and by sponsoring the interested and related research activities being carried out by various institutes and also by on-going business development partnerships.
To become a leading global pharmaceutical company. In next 5 years Arinna aims to achieve a turnover of 500 CR with having operations in therapy segments of CNS, CVD, Gynecology, Dermatology and Respiratory. In long-run Arinna aims to be leader in therapy segments of CNS, CVD & Dermatology.
At Arinna we are committed to build highest standards of transparency & integrity in our operations. We believe in creating relations based on mutual trust.
We are responsible to our customers and we work towards the delivery of highest levels of customer satisfaction.
Arinna is a people orientated organization. At Arinna we emphasize on Mutual Respect, Collaboration and Team Work. We make every effort to create conducive work environment for our employees to perform at their best.
VIVEK SETH
Managing Director
SHILPA VIVEK SETH
Director
ROHIT BRIJMOHAN MANTRI
Nominee Director
SHANKAR GOPALAKRISHNAN
Independent Director
SIDDHARTH SUBODHCHANDRA SHAH
Independent Director
The team Arinna is spearheaded by the veteran in the CNS segment who has an enviable track record of building CNS portfolio to 600 crore from a mere base of 20 crore, in a span of just 12 years with judicious utilisation of the available resources.
Experience over the years: The Team’s vast experience of more than two decades in the CNS segment, where in scaling a new level of achievement every year had been the driving force that led to carve out a niche for this team. The competition gave way to the passion of this team that had set a new standards of excellence.
Expertise of the domain: The decades of experience has taught several lessons to this Team and has thus, against all odds, emerged a winner all the time. The team has been in a position to innovate and evolve customer driven marketing strategies to have a win-win situation for the customers, its associates and the organization.
Trust of the Customer and Associates: With such an experience and thus, gaining an expertise, the Team has been in a privileged position to earn the trust of all its customers & associates. Now, the Team has dared to dream an organisation that has a passion to succeed with sincere commitment towards its customers and associates.
All the 3 divisions are spearheaded by the veteran in the CNS segment. All the divisions have products for therapeutic segments like epilepsy, depression, anxiety, schizophrenia, neuropathic pain, stroke and other supportive therapies.